Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1040
  • Dowloads 101

Case Reports

Open Access

Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report

  • N. Umesaki1,*,
  • T. Tanaka1
  • M. Miyama2
  • S. Ogita2,3
  • H. Ochi3,4

1Departmem of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Japan

2Department of Obstetrics and Gynecology, Japan

3Nuclear Medicine, Japan

4Osaka City University Medical School, Osaka, Japan

DOI: 10.12892/ejgo200104263 Vol.22,Issue 4,July 2001 pp.263-265

Published: 10 July 2001

*Corresponding Author(s): N. Umesaki E-mail:

PDF (3.29 MB) View Full-text

Abstract

When calcified lesions in the liver or spleen are found during follow-up of patients who have undergone debulking surgery and chemotherapy for advanced ovarian carcinoma, it is very difficult to differentiate recurrent cancer from secondary change after chemotherapy. We present here a patient in whom calcified lesions in the liver and spleen were diagnosed as malignancy on the basis of a preoperative PET study. Malignancy was confirmed by histologic examination after surgery.

Keywords

PET; Calcified lesion; Ovarian carcinoma; Serous cystadenocarcinoma; Psammoma body

Cite and Share

N. Umesaki,T. Tanaka,M. Miyama,S. Ogita,H. Ochi. Usefulness of positron emission tomography for diagnosis of malignancy in a calcified lesion: A case report. European Journal of Gynaecological Oncology. 2001. 22(4);263-265.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200104263

References

[I] Boring C., Squires T., Tony T., Montgomery S.: "Cancer statistics, 1994". CA., 1994, 44.

[2] Beecham J. B., Helmkamp B. F., Rubin P.: "Tumors of the female reproductive organs". In: Rubin P., ed. "Clinical Oncology: A muitidisciplinary approach", 6'h edition. American Cancer Society, 1983, 428.

[3] Umesaki N., Tanaka T., Miyama M., Kawamura N., Ogita S., Kawabe J. et al.: "Positron emission tomography with 18F-fluorodeoxyglucose for diagnosis of uterine sarcoma: A comparison with magnetic resonance imaging and power doppler imaging". Gynecol. Oneal., 2001, 80, 372.

[4] Ferenczy A., Talens M., Zoghby M., Hussain S. S.: "Ultrastructual studies on the morphogenesis of psammoma bodies in ovarian serous neoplasia". Cancer, 1977, 39, 2451.

[5] Castro J.R., .Klein E. W.: "The incidence and appearance of roentgenologically visible psammomatous calcification of papillary cystadenocarcinoma of the ovaries". Am. J. Roentgenol., 1962, 146, 886.

[6] Bagley C. M. Jr., Young R. C., Schein P. S., Chabner B. A., De Vita V. T.: "Ovarian carcinoma metastatic to the diaphragm frequently undiagnosed at laparotomy". Am. J. Obstet. Gynecol., 1973,116, 397.

[7] Feldman G. B., Knapp R. C.: "Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer". Am. J. Obstet. Gynecol., 1974, 119, 991.

[8] Straus L. G., Conti P. S.: "The application of PET in clinical oncology". J. Nucl. Med., 1991, 32, 623.

[9] Mitchell D. G., Hill M. C., Hill S. H., Zaloudek C.: "Serous carcinoma of the ovary: CT identification of metastatic calcified implants". Radiology, 1986, 158, 649.

[10] Hubner K. F., McDonald T. W., Niethammer J. G., Smith G. T., Gould H. R., Buonocore E.: "Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18-F] deoxyglucose (2-[18F] F DG)". Gynecol. Oncol., 1993, 51, 192.

[11] Sugawara Y., Eisbruch A., Kosuda S., Recker B. E., Kison P. V., Wahl R. L.: "Evaluation of FDG PET in patients with cervical cancer". J. Nucl. Med., 1999, 40, 1125.

[12] Umesaki N., Tanaka T., Miyama M., Tokuyama 0., Kawamura N., Ogita S. et al.: "Early diagnosis and evaluation of therapy in postoperative recurrent cervical cancers by positron emission tomography". Oncol. Rep., 2000, 7, 53.

Submission Turnaround Time

Top